Transaminasas séricas y síndrome metabólico en adultos mayores de 65 años de la sierra ecuatoriana / Serum transaminases and metabolic syndrome in adults older than 65 years old from the Ecuadorian highlands / Transaminases séricas e síndrome metabólica em adultos de mais de 65 anos da serra equatoriana

El objetivo del trabajo consistió en determinar la relación entre las transaminasas séricas y los componentes del Síndrome Metabólico (SM) en una población adulta mayor de 65 años de la sierra ecuatoriana. La misma estuvo formada por 387 adultos mayores de Cuenca-Ecuador. El diagnóstico de SM se realizó mediante los criterios del ATPIII-2005. Para la cuantificación de las transaminasas, alanina aminotransferasa (ALT) y aspartato aminotransferasa (AST) se usó el espectrofotómetro Génesis 20 con el reactivo de Wiener lab. Se compararon los grupos con y sin SM mediante el test t de Student. La correlación de Pearson se usó para medir la asociación entre los componentes del SM y de las transaminasas. La prevalencia del SM fue de 57,4% y de transaminasas alteradas del 12,4% y 9,0% para AST y ALT, respectivamente. Aunque se halló una correlación entre las AST, triglicéridos y C-HDL, no se encontró asociación directa entre el SM y las transaminasas. Estos resultados indican que es necesario profundizar el rol de las transaminasas séricas en la población de adultos mayores.

The objective of the present work was to determine the relationship between serum transaminases and the Metabolic Syndrome (MS) components in an elderly population from the Ecuadorian highlands. Said population was composed of 387 elderly people from Cuenca-Ecuador. The diagnosis of MS was made using the ATPIII-2005 criteria. For the quantification of transaminases alanine aminotransferase (ALT) and aspartate aminotransferase (AST), the Genesis 20 spectrophotometer was used with the reactive from the commercial house Wiener lab. The groups with and without MS were compared using Student's t test. Pearson's correlation was used to measure the association between SM components and transaminases. The prevalence of MS was 57.4%, for impaired transaminases 12.4% and 9.0% for AST and ALT respectively. Although a correlation was found between AST, triglycerides and C-HDL, no direct association between SM and transaminases was found. These results indicate that it is necessary to make more studies in the role of serum transaminases in the elderly population.

O objetivo do trabalho consistiu em determinar a relação entre as transaminases séricas e os componentes da Síndrome Metabólica (SM) numa população de adultos de mais de 65 anos da serra equatoriana. A população esteve constituída por 387 adultos idosos da Bacia-Equador. O diagnóstico de SM foi feito com base nos critérios do ATPIII-2005. Para a quantificação das transaminases alanina aminotransferase (ALT) e aspartato aminotransferase (AST) utilizou-se o espectrofotômetro Genesis 20 com o reagente de Wiener lab. Foram comparados os grupos com e sem SM utilizando o teste t de Student. Utilizou-se a correlação de Pearson para medir a associação entre os componentes da SM e das transaminases. A prevalência de SM foi de 57,4% e para transaminases alteradas de 12,4% e 9,0% para AST e ALT, respectivamente. Embora tenha sido encontrada correlação entre AST, triglicérides e C-HDL, não foi encontrada associação direta entre a SM e as transaminases. Estes resultados indicam que é necessário fazer mais estudos sobre o papel das transaminases séricas na população idosa.

Complement System and C4d expression in cases of Membranous nephropathy / Sistema complemento e expressão de C4d em casos de Glomerulopatia Membranosa

Abstract Introduction: Membranous nephropathy (MN) is one of the major causes of nephrotic syndrome. The complement system plays a key role in the pathophysiology of MN. Objectives: To identify the complement pathway possibly activated in MN cases and correlate the presence of C4d with more severe clinical and histological markers. Methods: Sixty nine cases from renal biopsy with membranous nephropathy were investigated. The presence of C1q was analyzed by direct immunofluorescence; and expression of C4d by immunohistochemistry. Clinical and epidemiological data were obtained upon biopsy request. Results: The presence of focal segmental glomerulosclerosis, global glomerulosclerosis, vascular lesions and tubulointerstitial fibrosis were collected by anatomopathological report. C4d(+) was found in 58 (84%), and C1q(+) was found in 12 (17%) of the cases. Twelve patients had C4d(+)/C1q(+), 46 had C4d(+)/C1q(-), and 11 patients had C4d(-)/C1q(-), probably indicating the activation of the classical, lectin and alternative pathways, respectively. Conclusion: C4d was associated with increased interstitial fibrosis, but not with clinical markers of poor prognosis. Through the deposition of C4d and C1q we demonstrated that all complement pathways may be involved in MN, highlighting the lectin pathway. The presence of C4d has been associated with severe tubulointerstitial lesions, but not with clinical markers, or can be taken as a universal marker of all cases of MN.

Resumo Introdução: A Glomerulopatia membranosa (GM) é uma das principais causas da síndrome nefrótica. O sistema do complemento desempenha um papel chave na fisiopatologia do GM. Objetivos: Identificar a via do complemento possivelmente ativada nos casos de GM e correlacionar a presença de C4d com marcadores clínicos e histológicos mais graves. Métodos: Foram investigados 69 casos de biópsia renal com GM. A presença de C1q foi analisada por imunofluorescência direta e a expressão de C4d por imunohistoquímica. Dados clínicos e epidemiológicos foram obtidos mediante solicitação de biópsia renal. Resultados: A presença de glomerulosclerose segmentar focal, glomeruloesclerose global, lesões vasculares e fibrose tubulointersticial foi coletada por relato anatomopatológico. C4d (+) foi encontrado em 58 (84%), e C1q (+) foi encontrado em 12 (17%) casos. Doze pacientes tinham C4d (+)/C1q (+), 46 tinham C4d (+)/C1q (-) e 11 pacientes tinham C4d (-)/C1q (-), indicando provavelmente a ativação da via clássica, da lectina e da alternativa, respectivamente. Conclusão: O C4d foi associado ao aumento da fibrose intersticial, mas não com marcador clínico de mau prognóstico. Através da deposição de C4d e C1q, demonstrou-se que todas as vias do complemento podem estar envolvidas em GM, destacando a via da lectina. A presença de C4d tem sido associada a lesões tubulointersticiais graves, mas não com marcadores clínicos, ou pode ser tomada como um marcador universal de todos os casos de GM.

Debilidad muscular y miopatía: nunca solicitar biopsia sin antes dosaje enzimático / Muscule weakness and myopathy: never get biopsy without previous enzyme assessment

La presencia de debilidad muscular progresiva asociada a valores elevados de creatininafosfoquinasa es una consulta frecuente en los servicios de Reumatología, debido a la sospecha de miopatías inflamatorias. La confirmación del diagnóstico se realiza por medio del hallazgo de infiltrado inflamatorio en la biopsia muscular, lo que lleva a un rápido inicio del tratamiento inmunosupresor. Otras entidades no relacionadas a procesos inflamatorios primarios pueden mostrar signos y síntomas similares y aún presentar signos de inflamación y necrosis en la biopsia muscular, lo que lleva a un tratamiento erróneo. La glucogenosis tipo II o enfermedad de Pompe debe ser incluida en la lista de diagnósticos diferenciales ante esta presentación clínica. La evaluación de la actividad enzimática por medio del dosaje en papel de filtro es una técnica simple que permite el arribo al diagnóstico sin necesidad de biopsia muscular, lo que llevará a un inicio de la terapia de reemplazo enzimático específica.

Muscle weakness related to high levels of creatinekinase is a commonconsultation in Reumatology departments, due suspicion of inflammatorymyopathies. Diagnosis confirmation requires inflammatory infiltratefindings in muscle biopsy, followed by immunosuppressor treatment.Other disorders not related to primary inflammatory process may showsimilar signs and symptoms, even necrosis and inflammation in musclebiopsy, resulting in a wrong treatment. Glycogenosis type II or Pompedisease should be included as another differential diagnosis. Enzymeactivity measurement using dried blood spot in filter paper is an easytechnique that results in diagnosis without the need of muscle biopsy,allowing the enzyme replacement therapy indication.

Mecanismos asociados a la resistencia al derribo "kdr" a la deltametrina en Aedes aegypti del occidente de Venezuela / Mechanisms associated with knockdown resistance to deltamethrin in Aedes aegypti from western Venezuela

Se determinaron los mecanismos bioquímicos y moleculares involucrados con la resistencia al derribo "kdr" a la deltametrina en poblaciones de Aedes aegypti de los estados Trujillo, Lara y Táchira. Las poblaciones fueron expuestas a CK50 previamente determinadas mediante bioensayos con botellas impregnadas siguiendo la metodología de Brogdon (1989) por 1h. Posteriormente los insectos fueron colocados en envases post-recuperación libres de insecticidas y separados en 4 fenotipos: los no derribados luego de 1h, los recuperados a las 4h, los supervivientes y los muertos a las 24 horas post-exposición. Todos los ejemplares fueron seccionados; con cabeza y tórax se determinaron los niveles de esterasas α y β, oxidasas de función múltiple, glutation S transferasas y acetilcolinesterasa insensible y con el abdomen se extrajo ADN y se realizaron PCR para amplificar los alelos específicos Val1016 e Ile1016. Las enzimas desintoxicantes se incrementaron en la mayoría de las poblaciones entre las 4 y 24h posteriores a la exposición a la deltametrina sin encontrarse diferencia significativa con los niveles expresados en la cepa susceptible New Orleans (NO), excepto en la población de Ureña donde se encontró aumento significativo en las β-esterasas siendo superiores en el fenotipo superviviente con respecto al fenotipo muertos a las 24h. El genotipo silvestre V1016/V1016 prevaleció sobre el heterocigoto y homocigoto mutante en los cuatro fenotipos, en la mayoría de las poblaciones estudiadas, con excepción de la población Ureña donde el homocigoto mutante I1016/I1016 fue el genotipo predominante en los no derribados, lo cual se vio reflejado en la frecuencia alélica. Se asocia la mutación V1016I con la resistencia al derribo mostrada en las poblaciones evaluadas, destacando la importancia de la temprana detección de esta y otras mutaciones en el canal del sodio asociadas con resistencia a piretroides, lo cual debe ser considerado antes de incorporar el uso de deltametrina en el programa de control de Ae. aegypti en estas poblaciones.

The biochemical and molecular mechanisms associated with resistance to deltamethrin were determined in female Aedes aegypti taken from different mosquito populations captured in Trujillo, Lara and Tachira states. Individuals from each population were subjected to 1 h of exposure to deltamethrin using the CK50 previously determined by the bottle bioassay. The mosquitoes were then placed in containers free from insecticide and separated into 4 phenotypes: mosquitoes that were not knocked down after 1 h of exposure, those that recovered 4 h after exposure, those that were still alive 24 h after exposure and those that were dead at 24 h. Each of the mosquitoes in these groups was then dissected to separate the head-thorax, and abdomen. Biochemical tests were performed on the head-thorax to determine the presence of resistance-related enzymes including: α-and β-esterases, glutathione S-transferase and insensitive acetylcholinesterase. The abdomen was used for molecular tests to amplify the specific allele Val 1016 and Ile 1016. The quantities of detoxifying enzymes increased between 4 and 24 h after exposure to deltamethrin in mosquitoes from most of the populations tested although no significant differences between these and the susceptible New Orleans strain (NO) were found, except for mosquitoes from the Ureña population which showed a significant increase in β-esterase with higher values in the "survivors" phenotype compared to the "dead" phenotype at 24 h. The wild genotype V1016/V1016 prevailed over the heterozygous and homozygous mutants in the four phenotypes in the majority of the populations studied, with exception of the Ureña population where the resistant homozygote I1016/I1016 was the predominant genotype. The V1016I mutation was associated with the knockdown resistance observed in the evaluated populations emphasizing the importance of the early detection of this and other mutations in the sodium channel which have been linked with resistance to pyrethroids. These aspects should be considered before applying deltamethrin to control these Ae. Aegypti populations.